Published in PLoS One on December 12, 2014
Paracelsus Revisited: The Dose Concept in a Complex World. Basic Clin Pharmacol Toxicol (2016) 0.79
Toxicant exposure and bioaccumulation: a common and potentially reversible cause of cognitive dysfunction and dementia. Behav Neurol (2015) 0.78
Preconception Care: A New Standard of Care within Maternal Health Services. Biomed Res Int (2016) 0.76
Is academic medicine for sale? N Engl J Med (2000) 5.21
Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci (2007) 4.82
Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect (2007) 4.28
The C8 health project: design, methods, and participants. Environ Health Perspect (2009) 2.78
Perfluorinated compounds--exposure assessment for the general population in Western countries. Int J Hyg Environ Health (2008) 2.06
Enhanced elimination of perfluorooctane sulfonic acid by menstruating women: evidence from population-based pharmacokinetic modeling. Environ Sci Technol (2014) 2.06
Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect (2006) 1.70
Binding of perfluorinated fatty acids to serum proteins. Environ Toxicol Chem (2003) 1.45
Intrinsic human elimination half-lives of polychlorinated biphenyls derived from the temporal evolution of cross-sectional biomonitoring data from the United Kingdom. Environ Health Perspect (2010) 1.43
Association of brominated flame retardants with diabetes and metabolic syndrome in the U.S. population, 2003-2004. Diabetes Care (2008) 1.38
Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ Res (2005) 1.33
Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate. Fundam Appl Toxicol (1984) 1.33
Immunotoxicity of perfluorinated compounds: recent developments. Toxicol Pathol (2011) 1.30
Perfluorinated alkyl acids in blood serum from primiparous women in Sweden: serial sampling during pregnancy and nursing, and temporal trends 1996-2010. Environ Sci Technol (2012) 1.27
Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. Environ Health Perspect (2010) 1.16
Elimination of persistent toxicants from the human body. Hum Exp Toxicol (2010) 1.13
Implications of early menopause in women exposed to perfluorocarbons. J Clin Endocrinol Metab (2011) 1.07
Perfluorinated compounds affect the function of sex hormone receptors. Environ Sci Pollut Res Int (2013) 1.05
Exploring the continuum: medical information to effective clinical practice. Paper I: the translation of knowledge into clinical practice. J Eval Clin Pract (2006) 1.03
Elimination half-life of drugs: value and limitations. Annu Rev Med (1985) 1.02
Alterations in cell membrane properties caused by perfluorinated compounds. Comp Biochem Physiol C Toxicol Pharmacol (2003) 1.00
Background exposure to persistent organic pollutants predicts stroke in the elderly. Environ Int (2012) 0.98
Perfluorinated compounds in maternal serum and cord blood from selected areas of South Africa: results of a pilot study. J Environ Monit (2010) 0.97
History of evidence-based medicine. Oranges, chloride of lime and leeches: barriers to teaching old dogs new tricks. Emerg Med Australas (2005) 0.97
Perfluorochemicals and endometriosis: the ENDO study. Epidemiology (2012) 0.94
Alterations in gene expression and testosterone synthesis in the testes of male rats exposed to perfluorododecanoic acid. Toxicol Sci (2007) 0.91
Isomer profiles of perfluorochemicals in matched maternal, cord, and house dust samples: manufacturing sources and transplacental transfer. Environ Health Perspect (2011) 0.90
Association between maternal exposure to perfluorooctanoic acid (PFOA) from electronic waste recycling and neonatal health outcomes. Environ Int (2012) 0.89
Mode of Action analysis of perfluorooctanoic acid (PFOA) tumorigenicity and Human Relevance. Reprod Toxicol (2011) 0.88
Perfluorooctanoic acid induces apoptosis through the p53-dependent mitochondrial pathway in human hepatic cells: a proteomic study. Toxicol Lett (2013) 0.87
An assessment of the intestinal lumen as a site for intervention in reducing body burdens of organochlorine compounds. ScientificWorldJournal (2013) 0.87
Perfluorinated compound levels in cord blood and neurodevelopment at 2 years of age. Epidemiology (2013) 0.87
Biomonitoring of perfluoroalkyl acids in human urine and estimates of biological half-life. Environ Sci Technol (2013) 0.87
Phthalate and bisphenol A exposure among pregnant women in Canada--results from the MIREC study. Environ Int (2014) 0.86
Distributions of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in Japan and their toxicities. Environ Sci (2005) 0.86
Human detoxification of perfluorinated compounds. Public Health (2010) 0.84
Mechanism of cytotoxic action of perfluorinated acids II. Disruption of mitochondrial bioenergetics. Toxicol Appl Pharmacol (2008) 0.84
Exceptionally high serum concentrations of perfluorohexanesulfonate in a Canadian family are linked to home carpet treatment applications. Environ Sci Technol (2012) 0.84
Medical practice and community health care in the 21st century: a time of change. Public Health (2008) 0.83
PFOS or PreFOS? Are perfluorooctane sulfonate precursors (PreFOS) important determinants of human and environmental perfluorooctane sulfonate (PFOS) exposure? J Environ Monit (2010) 0.82
DEHP-plasticised PVC: relevance to blood services. Transfus Med (2010) 0.82
Perfluorooctanoic acid induces gene promoter hypermethylation of glutathione-S-transferase Pi in human liver L02 cells. Toxicology (2012) 0.82
A single neonatal exposure to perfluorohexane sulfonate (PFHxS) affects the levels of important neuroproteins in the developing mouse brain. Neurotoxicology (2013) 0.81
Biomonitoring and Elimination of Perfluorinated Compounds and Polychlorinated Biphenyls through Perspiration: Blood, Urine, and Sweat Study. ISRN Toxicol (2013) 0.80
Gastrointestinal Elimination of Perfluorinated Compounds Using Cholestyramine and Chlorella pyrenoidosa. ISRN Toxicol (2013) 0.80
Perfluorinated compounds: emerging POPs with potential immunotoxicity. Toxicol Lett (2014) 0.80
Endocrine-Disrupting Chemicals: Some Actions of POPs on Female Reproduction. Int J Endocrinol (2013) 0.79
Partitioning of perfluorooctanesulfonate and perfluorohexanesulfonate in the aquatic environment after an accidental release of aqueous film forming foam at Schiphol Amsterdam Airport. Environ Toxicol Chem (2014) 0.76
Relationship between blood/air partition coefficients of lipophilic organic solvents and blood triglyceride levels. Toxicology (2000) 0.76
PFOA and cancer in a highly exposed community: new findings from the C8 science panel. Environ Health Perspect (2013) 0.76